Drawing for HRA

USPTO serial 85671952

HRA

Reviewed by CopyMark Law Group

Reg. 4363571Status 800Registered
Filing date
Status date
Registration date
Jul 9, 2013
Examiner
DUBRAY, KATHERINE M
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with HRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shannon Hennessy Pulaski

Shannon Hennessy Pulaski THE LAW OFFICE OF SHANNON HENNESSY PULASKI, LLC1601 Perrineville Road #7337MONROE TOWNSHIP, NJ 08831United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable electronic publications in the nature of periodic reports in the pharmaceutical, biomedical, and medical devices fields, namely, medical information on products, markets, industry, technologies, treatment, companies, procedures and therapies; downloadable electronic reports and databases on the subjects of pharmaceutical, biomedical, and medical device, and other medical products used in hospitals; downloadable electronic reports and databases on the subjects of the markets for, and usage of, such pharmaceuticals, biomedical products, and medical devices or other equipment and products used in hospitals; downloadable webinars in the field of medical information on products, markets, industry, technologies, treatment, companies, procedures and therapies; downloadable electronic reports regarding forecasts and analysis of current emerging technologies, their applications and markets; electronic reports regarding various products for markets, industries and technologies related to medical disorders; downloadable electronic reports and databases for research, development, marketing and planning in the pharmaceutical industryACTIVE—
035Syndicated market research for healthcare and pharmaceutical, biomedical, and medical device companies; marketing consulting and primary market research services in the field of healthcare for pharmaceutical, biomedical, and medical device manufacturers with respect to market access, managed markets, retail and hospital pharmacy, pricing and reimbursement; Conducting business and market research surveys, market research, market analysis, business marketing consulting services, sales research and consulting, economic forecasting and analysis in the healthcare field, measurement of sales force effectiveness and identification of business strategies to improve effectiveness, all of the aforementioned services for pharmaceutical, biomedical, and medical device manufacturers; provision of business, marketing, and economic information in the field of physician groups services, health systems and hospitals, HMOs and insurance providers, regional market data, drug product and customer response data; providing an online computer database for advertising and marketing in the pharmaceutical, biomedical and medical device industries; business consulting services regarding databases for pharmaceutical, biomedical, and medical device research, marketing, development; business data analysis in the field of prescription drugsACTIVE—
038Providing online access to computer databases for pharmaceutical, biomedical, and medical device marketing and business planning; providing online access to computer databases for biopharmaceutical research and developmentACTIVE—
042Providing an online computer database for product research, development and planning in the pharmaceutical, biomedical, and medical device industriesACTIVE—
044Consulting services in the field of healthcare for pharmaceutical, biomedical, and medical device manufacturers; provision of healthcare information in the field of physician groups services, health systems and hospitals, HMOs and insurance providers, regional market data, drug product and customer response data; providing information in the field of medical disorders, namely, information on products that are available for use in connection with various medical technologies, medical treatments and medical therapies, information on the companies and industries that are providing and developing such products, technologies, treatments and therapies, and information on the current and potential markets for such products, technologies, treatments and therapies; providing information in the field of medical disorders, namely, information on medical products, medical technologies, medical treatments and medical therapiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 23, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 23, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 23, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 30, 2023NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Dec 30, 2023RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Dec 30, 202389AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Dec 29, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 30, 2023E89RTEAS SECTION 8 & 9 RECEIVED—
Jul 9, 2022REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Aug 7, 2019NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Aug 7, 2019C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Aug 7, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 24, 2019E815TEAS SECTION 8 & 15 RECEIVED—
Jul 9, 2018REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 25, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 5, 2014ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 9, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 31, 2013ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Feb 7, 2013ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 15, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 15, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 26, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 12, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 11, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 30, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 30, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 28, 2012ALIEASSIGNED TO LIE—
Nov 20, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 1, 2012GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2012GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 25, 2012DOCKASSIGNED TO EXAMINER—
Jul 17, 2012MPMKNOTICE OF PSEUDO MARK MAILED—
Jul 16, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 12, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance